Sat, May
7 New Articles

Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets.

More Articles ...

Sign up via our free email subscription service to receive notifications when new information is available.